Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$359M |
| 2 |
Ameren
AEE
|
+$68.9M |
| 3 |
CMS Energy
CMS
|
+$36.8M |
| 4 |
PayPal
PYPL
|
+$35.6M |
| 5 |
Entergy
ETR
|
+$31.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aramark
ARMK
|
+$150M |
| 2 |
Las Vegas Sands
LVS
|
+$62.2M |
| 3 |
American Electric Power
AEP
|
+$36.3M |
| 4 |
Oracle
ORCL
|
+$30.2M |
| 5 |
Apple
AAPL
|
+$27.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 13.47% |
| 2 | Technology | 10.64% |
| 3 | Financials | 6.44% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Consumer Staples | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
BiomX
PHGE
$3.56M
| $232K | ﹤0.01% |
+126
| New | +$217K |
|
|
SPNE
1277
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $232K | ﹤0.01% |
+19,300
| New | +$236K |
|
1278
Ormat Technologies
ORA
$6.48B
| $231K | ﹤0.01% |
+3,100
| New | +$235K |
|
1279
Western Union
WU
$2.28B
| $231K | ﹤0.01% |
+8,614
| New | +$223K |
|
|
VNET
1280
VNET Group
VNET
$1.84B
| $229K | ﹤0.01% |
+31,655
| New | +$240K |
|
1281
BJs Wholesale Club
BJ
$12.6B
| $228K | ﹤0.01% |
10,021
-22,285
| -69% | -$551K |
|
1282
Levi Strauss
LEVI
$8.36B
| $228K | ﹤0.01% |
+11,800
| New | +$210K |
|
1283
The RMR Group
RMR
$336M
| $228K | ﹤0.01% |
+4,985
| New | +$231K |
|
1284
A10 Networks
ATEN
$1.83B
| $227K | ﹤0.01% |
+33,100
| New | +$223K |
|
1285
Grand Canyon Education
LOPE
$3.85B
| $227K | ﹤0.01% |
2,369
-1,231
| -34% | -$114K |
|
1286
Park National Corp
PRK
$3.68B
| $227K | ﹤0.01% |
2,216
-111
| -5% | -$11.1K |
|
1287
Interface
TILE
$2.21B
| $227K | ﹤0.01% |
13,672
+1,914
| +16% | +$30.8K |
|
1288
Royal Bank of Canada
RY
$284B
| $226K | ﹤0.01% |
+2,856
| New | +$230K |
|
1289
Upbound Group
UPBD
$1.12B
| $226K | ﹤0.01% |
7,841
-1,775
| -18% | -$46.4K |
|
|
EVBG
1290
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $226K | ﹤0.01% |
2,891
-609
| -17% | -$47K |
|
1291
Kemper
KMPR
$1.63B
| $225K | ﹤0.01% |
+2,898
| New | +$216K |
|
1292
Lennox International
LII
$13.8B
| $224K | ﹤0.01% |
919
-90
| -9% | -$22.3K |
|
|
CNR
1293
Core Natural Resources Inc
CNR
$4.78B
| $224K | ﹤0.01% |
15,458
-2,940
| -16% | -$40.6K |
|
1294
Origin Bancorp
OBK
$1.64B
| $223K | ﹤0.01% |
+5,899
| New | +$207K |
|
|
AGRX
1295
DELISTED
Agile Therapeutics
AGRX
| $223K | ﹤0.01% |
+45
| New | +$157K |
|
1296
Costamare
CMRE
$1.88B
| $222K | ﹤0.01% |
+23,326
| New | +$186K |
|
1297
Middlesex Water
MSEX
$1.12B
| $222K | ﹤0.01% |
+3,499
| New | +$222K |
|
1298
Advanced Drainage Systems
WMS
$10.6B
| $222K | ﹤0.01% |
5,726
-7,088
| -55% | -$262K |
|
|
PTLA
1299
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $222K | ﹤0.01% |
9,288
-1,587
| -15% | -$43.8K |
|
|
EXAS
1300
DELISTED
Exact Sciences
EXAS
| $221K | ﹤0.01% |
2,385
-515
| -18% | -$45.3K |
|
Similar funds
Michael Gelband's Q4 2019 Portfolio in Review
As of Q4 2019, Michael Gelband held 2,083 positions worth $5.33B, up 86% from $2.86B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Michael Gelband deployed $2.23B of net new capital in Q4 2019, opening 789 new positions and adding to 411 existing holdings. Its largest new stake was PayPal: 341,834 shares worth $37M.
By sector, the portfolio is most concentrated in Utilities at 13% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Aramark, an estimated $150M trimmed.
- Michael Gelband's largest Q4 2019 buy was PayPal: 341,834 shares worth $37M.
- Michael Gelband added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $359M increase.
- Michael Gelband's biggest Q4 2019 reduction was Aramark, cutting an estimated $150M.
- Michael Gelband fully exited Las Vegas Sands in Q4 2019, selling an estimated $62.2M.
- Michael Gelband's ten largest holdings make up 42% of its $5.33B portfolio in Q4 2019.
- Michael Gelband opened 789 new positions and closed 597 in Q4 2019.
- Michael Gelband's portfolio value rose 86% quarter-over-quarter to $5.33B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.